Kim Hyun S, Fine Derek M, Atta Mohamed G
Division of Vascular and Interventional Radiology, Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Blalock 545, Baltimore, Maryland 21205, USA.
J Vasc Interv Radiol. 2006 May;17(5):815-22. doi: 10.1097/01.RVI.0000209341.88873.26.
To evaluate the technical success and clinical outcome of the percutaneous treatment of acute renal vein thrombosis (RVT).
Retrospective review was conducted of all patients with acute RVT treated with percutaneous catheter-directed thrombectomy with or without thrombolysis at one institution between 2000 and 2004. Demographics, comorbid conditions, and clinical outcomes associated with therapy were assessed.
Seven thrombosed renal veins in six patients (mean age, 51.5 +/- 18.8 years) were treated with percutaneous catheter-directed thrombectomy/thrombolysis. Thrombosed renal veins included two allografts and five native veins, and diagnosis was confirmed in all cases by direct renal venography. Inferior vena cava thrombosis was the cause of RVT in one patient, and glomerulopathy was the cause in the remaining patients. Percutaneous mechanical thrombectomy was performed in all cases, and five renal veins were additionally treated with thrombolysis for a mean duration of 22.1 +/- 21.0 hours. Restoration of flow to renal veins was achieved in all thrombosed renal veins. Clinical improvement occurred in all patients: the mean serum creatinine level improved from a preoperative level of 3.3 +/- 1.92 mg/dL to a postoperative level of 1.92 +/- 1.32 mg/dL (P = .008). Mean glomerular filtration rate improved from a preoperative level of 30.8 +/- 23.0 mL/min per 1.73 m(2) to 64.2 +/- 52.4 mL/min per 1.73 m(2) (P = .04). There were no pulmonary emboli or hemorrhagic complications, and no RVT recurrence was documented during a median follow-up of 22.5 months.
Percutaneous catheter-directed thrombectomy with or without thrombolysis for acute RVT is associated with a rapid improvement in renal function and low incidence of morbidity. It is feasible for native and allograft renal veins and should be considered in patients with acute RVT, particularly in the setting of deteriorating renal function.
评估经皮治疗急性肾静脉血栓形成(RVT)的技术成功率和临床疗效。
对2000年至2004年间在一家机构接受经皮导管直接血栓切除术(伴或不伴溶栓)治疗的所有急性RVT患者进行回顾性研究。评估人口统计学、合并症以及与治疗相关的临床疗效。
6例患者(平均年龄51.5±18.8岁)的7条肾静脉血栓接受了经皮导管直接血栓切除术/溶栓治疗。血栓形成的肾静脉包括2条移植肾静脉和5条自身肾静脉,所有病例均经直接肾静脉造影确诊。1例患者的RVT病因是下腔静脉血栓形成,其余患者的病因是肾小球病。所有病例均进行了经皮机械性血栓切除术,5条肾静脉额外接受了平均时长为22.1±21.0小时的溶栓治疗。所有血栓形成的肾静脉均实现了血流恢复。所有患者的临床症状均有改善:血清肌酐平均水平从术前的3.3±1.92mg/dL降至术后的1.92±1.32mg/dL(P = 0.008)。平均肾小球滤过率从术前的每1.73m² 30.8±23.0mL/min提高至每1.73m² 64.2±52.4mL/min(P = 0.04)。未发生肺栓塞或出血并发症,在中位随访22.5个月期间未记录到RVT复发。
经皮导管直接血栓切除术(伴或不伴溶栓)治疗急性RVT可使肾功能迅速改善,且发病率低。该方法对于自身肾静脉和移植肾静脉均可行,对于急性RVT患者,尤其是肾功能恶化的患者,应考虑采用。